| Screened patients | 186 |
| Screening failure | |
| Total | 45/186 (24.2) |
| LAA anatomy | 38/186 (20.4) |
| Thrombus detected by TOE | 7/186 (3.8) |
| N patients undergoing LAA ligation attempt | 141 |
| Age (years) | 70.4 ± 12.2 |
| N female patients | 62/141 (44.0) |
| Type of AF | |
| Paroxysmal | 67/141 (47.5) |
| Persistent | 30/141 (21.3) |
| Longstanding persistent | 44/141 (31.2) |
| N patients with previous stroke | 13/141 (9.2) |
| N patients with previous bleeding event | 30/141 (21.3) |
| CHA2DS2-VASc score | 3 [2; 4] |
| Reason for LAA ligation | |
| Contraindication/intolerance to OAC | 113/141 (80.1) |
| Prevention of LAA thrombus formation after LAA electrical isolation | 23 (16.3) |
| Adjunctive to PVI | 5 (3.5) |
| Screened patients | 186 |
| Screening failure | |
| Total | 45/186 (24.2) |
| LAA anatomy | 38/186 (20.4) |
| Thrombus detected by TOE | 7/186 (3.8) |
| N patients undergoing LAA ligation attempt | 141 |
| Age (years) | 70.4 ± 12.2 |
| N female patients | 62/141 (44.0) |
| Type of AF | |
| Paroxysmal | 67/141 (47.5) |
| Persistent | 30/141 (21.3) |
| Longstanding persistent | 44/141 (31.2) |
| N patients with previous stroke | 13/141 (9.2) |
| N patients with previous bleeding event | 30/141 (21.3) |
| CHA2DS2-VASc score | 3 [2; 4] |
| Reason for LAA ligation | |
| Contraindication/intolerance to OAC | 113/141 (80.1) |
| Prevention of LAA thrombus formation after LAA electrical isolation | 23 (16.3) |
| Adjunctive to PVI | 5 (3.5) |
AF, atrial fibrillation; LAA, left atrial appendage; OAC, oral anticoagulation; PVI, pulmonary vein isolation; TOE, transoesophageal echocardiography.
| Screened patients | 186 |
| Screening failure | |
| Total | 45/186 (24.2) |
| LAA anatomy | 38/186 (20.4) |
| Thrombus detected by TOE | 7/186 (3.8) |
| N patients undergoing LAA ligation attempt | 141 |
| Age (years) | 70.4 ± 12.2 |
| N female patients | 62/141 (44.0) |
| Type of AF | |
| Paroxysmal | 67/141 (47.5) |
| Persistent | 30/141 (21.3) |
| Longstanding persistent | 44/141 (31.2) |
| N patients with previous stroke | 13/141 (9.2) |
| N patients with previous bleeding event | 30/141 (21.3) |
| CHA2DS2-VASc score | 3 [2; 4] |
| Reason for LAA ligation | |
| Contraindication/intolerance to OAC | 113/141 (80.1) |
| Prevention of LAA thrombus formation after LAA electrical isolation | 23 (16.3) |
| Adjunctive to PVI | 5 (3.5) |
| Screened patients | 186 |
| Screening failure | |
| Total | 45/186 (24.2) |
| LAA anatomy | 38/186 (20.4) |
| Thrombus detected by TOE | 7/186 (3.8) |
| N patients undergoing LAA ligation attempt | 141 |
| Age (years) | 70.4 ± 12.2 |
| N female patients | 62/141 (44.0) |
| Type of AF | |
| Paroxysmal | 67/141 (47.5) |
| Persistent | 30/141 (21.3) |
| Longstanding persistent | 44/141 (31.2) |
| N patients with previous stroke | 13/141 (9.2) |
| N patients with previous bleeding event | 30/141 (21.3) |
| CHA2DS2-VASc score | 3 [2; 4] |
| Reason for LAA ligation | |
| Contraindication/intolerance to OAC | 113/141 (80.1) |
| Prevention of LAA thrombus formation after LAA electrical isolation | 23 (16.3) |
| Adjunctive to PVI | 5 (3.5) |
AF, atrial fibrillation; LAA, left atrial appendage; OAC, oral anticoagulation; PVI, pulmonary vein isolation; TOE, transoesophageal echocardiography.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
